$89,000 Orphan Drug Gets A New Owner — And Likely A New Price
Marathon, maker of an expensive treatment for Duchenne muscular dystrophy, sells the drug for $140 million in cash and stock to PTC Therapeutics.
All Coverage
-
-
Repeal & Replace Watch
Many Californians Could Be Priced Out Of Exchange Coverage, Analysis Finds
California’s health insurance exchange released an analysis showing that Republicans’ plan to trim subsidies, on average, by 40% would fall hard on elderly and very low-income people, especially in expensive areas like San Francisco.
-
Repeal & Replace Watch
Obamacare Pushed Nonprofit Hospitals To Do Good Beyond Their Walls. Now What?
A provision in the 2010 health law required these hospitals to justify their tax exemption by demonstrating involvement in community health. Repeal, replace or repair could stall that momentum.
-
Repeal & Replace Watch
Once Nearly Buried By Medical Bills, Farmer Braces For Insurance Drought
Barton County, Mo., is Trump country. And this rural area has big problems when it comes to health care. One farmer says he has a lot to lose under the Republican replacement plan.
-
Experimental Stem Cell Treatment Leaves Three Women Blind
Researchers, who detail the women’s experiences in the New England Journal of Medicine, say it exposes the need for better regulation of clinical trials.
-
Repeal & Replace Watch
Health Exchange Enrollment Misses Obama Administration’s Goal, But Stays Steady
Federal officials said 12.2 million people signed up for plans this year on the health law’s marketplaces, down slightly from 2016.
-
Where You Live May Determine How You Die. Oregon Leads The Way.
A state with integrated systems for end-of-life care offers better treatment for the seriously ill, according to a new study.
-
Treating Cancer: Hope Vs. Hype
Sticker Shock Forces Thousands Of Cancer Patients To Skip Drugs, Skimp On Treatment
A growing number of patients fail to fill prescriptions because the cost of cancer drugs is too high.
-
Repeal & Replace Watch
By The Numbers: Trump’s Choice For FDA Chief Is Versatile, Entrenched In Pharma
The numbers show that President Trump’s choice for FDA commissioner, Scott Gottlieb, has long-standing ties to pharmaceutical companies as a board member or consultant and that he had to recuse himself multiple times while working at the FDA.
-
Repeal & Replace Watch
Americans Not Sold On Cost And Coverage Claims In GOP’s Health Bill
Nearly half of the people in this month’s Kaiser Family Foundation tracking poll believe the Republican legislation will increase the number of uninsured Americans and increase coverage costs.
-
Two Words Can Soothe Patients Who Have Been Harmed: We’re Sorry
For patients killed or maimed by medical errors, doctors and hospitals still often deny wrongdoing. But newer programs offering prompt disclosure of medical errors, an apology and compensation for them or their families are growing.
-
Proposed Law Would Require All California Children To Be Screened For Lead
Under the current statute, kids are tested for lead only if they’re on certain government programs or live in older buildings. That leaves many other California children at risk, lawmaker says.
-
Repeal & Replace Watch
Companies Behind Health Savings Accounts Could Bank On Big Profits Under GOP Plan
With Republicans in control of Congress and the White House, HSAs — a longtime favorite of conservatives — are likely to get a boost.
-
Repeal & Replace Watch
Families To Pay Price If Maternity Care Coverage Is Cut By GOP
Before the health law, buying an individual policy that included coverage for pregnancy and labor was extremely difficult.
-
Repeal & Replace Watch
Deciphering CBO’s Estimates On The GOP Health Bill
The federal government’s budget experts estimate that the Republican plan would reduce the deficit but dramatically drive up the number of uninsured.
-
Repeal & Replace Watch
Say What? Fact-Checking The Chatter Around The GOP Health Bill
In the heated political arguments as Republicans rush to repeal and replace the Affordable Care Act, some facts can get buried.
-
Repeal & Replace Watch
KHN On Call: How Retooled Health Law Might Treat Those With A History Of Illness
People with preexisting conditions will still be able to buy coverage under the GOP plan, but it’s not clear there will be plans anyone can afford.
-
By Law, Hospitals Now Must Tell Medicare Patients When Care Is ‘Observation’ Only
Not being officially admitted — a status known as observation care — can have financial consequences for beneficiaries, and patients had often complained they were not informed.
-
HMO Doctors Take Pains To Slash Opioid Prescriptions
A Kaiser Permanente pain management program in Southern California aims to help patients taper off addictive painkillers. Some doctors and patients see it as a godsend; others complain that patients have been cut off medications they need.
-
Repeal & Replace Watch
GOP Health Plan Could Be Bitter Pill For California’s Obamacare Exchange
Critics say the proposed changes could poison one of the nation’s healthiest marketplaces, driving up premiums and drawing in only the sickest patients. Republicans and industry analysts call those concerns overblown.
